• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年心房颤动患者心率控制与节律控制的选择及结局:REPOSI研究报告

Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.

作者信息

Paciullo Francesco, Proietti Marco, Bianconi Vanessa, Nobili Alessandro, Pirro Matteo, Mannucci Pier Mannuccio, Lip Gregory Y H, Lupattelli Graziana

机构信息

Unit of Internal Medicine, Department of Medicine, University of Perugia, Piazzale Menghini, Sant'Andrea delle Fratte, 06132, Perugia, Italy.

Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy.

出版信息

Drugs Aging. 2018 Apr;35(4):365-373. doi: 10.1007/s40266-018-0532-8.

DOI:10.1007/s40266-018-0532-8
PMID:29564755
Abstract

BACKGROUND

Among rate-control or rhythm-control strategies, there is conflicting evidence as to which is the best management approach for non-valvular atrial fibrillation (AF) in elderly patients.

DESIGN

We performed an ancillary analysis from the 'Registro Politerapie SIMI' study, enrolling elderly inpatients from internal medicine and geriatric wards.

METHODS

We considered patients enrolled from 2008 to 2014 with an AF diagnosis at admission, treated with a rate-control-only or rhythm-control-only strategy.

RESULTS

Among 1114 patients, 241 (21.6%) were managed with observation only and 122 (11%) were managed with both the rate- and rhythm-control approaches. Of the remaining 751 patients, 626 (83.4%) were managed with a rate-control-only strategy and 125 (16.6%) were managed with a rhythm-control-only strategy. Rate-control-managed patients were older (p = 0.002), had a higher Short Blessed Test (SBT; p = 0.022) and a lower Barthel Index (p = 0.047). Polypharmacy (p = 0.001), heart failure (p = 0.005) and diabetes (p = 0.016) were more prevalent among these patients. Median CHADS-VASc score was higher among rate-control-managed patients (p = 0.001). SBT [odds ratio (OR) 0.97, 95% confidence interval (CI) 0.94-1.00, p = 0.037], diabetes (OR 0.48, 95% CI 0.26-0.87, p = 0.016) and polypharmacy (OR 0.58, 95% CI 0.34-0.99, p = 0.045) were negatively associated with a rhythm-control strategy. At follow-up, no difference was found between rate- and rhythm-control strategies for cardiovascular (CV) and all-cause deaths (6.1 vs. 5.6%, p = 0.89; and 15.9 vs. 14.1%, p = 0.70, respectively).

CONCLUSION

A rate-control strategy is the most widely used among elderly AF patients with multiple comorbidities and polypharmacy. No differences were evident in CV death and all-cause death at follow-up.

摘要

背景

在心率控制或节律控制策略中,关于哪种是老年患者非瓣膜性心房颤动(AF)的最佳管理方法,证据存在冲突。

设计

我们对“Registro Politerapie SIMI”研究进行了一项辅助分析,纳入了内科和老年病房的老年住院患者。

方法

我们纳入了2008年至2014年入院时诊断为AF且仅采用心率控制或仅采用节律控制策略治疗的患者。

结果

在1114例患者中,241例(21.6%)仅接受观察,122例(11%)同时采用心率和节律控制方法。在其余751例患者中,626例(83.4%)仅采用心率控制策略,125例(16.6%)仅采用节律控制策略。采用心率控制的患者年龄更大(p = 0.002),简易精神状态检查表(SBT)评分更高(p = 0.022),巴氏指数更低(p = 0.047)。这些患者中多重用药(p = 0.001)、心力衰竭(p = 0.005)和糖尿病(p = 0.016)更为普遍。采用心率控制的患者CHADS-VASc评分中位数更高(p = 0.001)。SBT[比值比(OR)0.97,95%置信区间(CI)0.94 - 1.00,p = 0.037]、糖尿病(OR 0.48,95% CI 0.26 - 0.87,p = 0.016)和多重用药(OR 0.58,95% CI 0.34 - 0.99,p = 0.045)与节律控制策略呈负相关。随访时,心率控制和节律控制策略在心血管(CV)死亡和全因死亡方面无差异(分别为6.1%对5.6%,p = 0.89;15.9%对14.1%,p = 0.70)。

结论

在患有多种合并症和多重用药的老年AF患者中,心率控制策略使用最为广泛。随访时CV死亡和全因死亡方面无明显差异。

相似文献

1
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.老年心房颤动患者心率控制与节律控制的选择及结局:REPOSI研究报告
Drugs Aging. 2018 Apr;35(4):365-373. doi: 10.1007/s40266-018-0532-8.
2
Atrial Fibrillation: Possible Influences of Rate and Rhythm Control Strategy on Cognitive Performance.心房颤动:心率和节律控制策略对认知表现的可能影响。
J Am Geriatr Soc. 2018 Nov;66(11):2178-2182. doi: 10.1111/jgs.15568. Epub 2018 Oct 3.
3
Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.焦虑敏感在心房颤动和充血性心力衰竭患者的节律控制与心率控制策略的预后重要性中起调节作用:来自心房颤动和充血性心力衰竭试验的见解。
Circ Heart Fail. 2012 May 1;5(3):322-30. doi: 10.1161/CIRCHEARTFAILURE.111.964122. Epub 2012 Mar 22.
4
Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.治疗 90 岁以上老年人的心房颤动:来自柏林心房颤动(BAF)登记研究的见解。
J Am Med Dir Assoc. 2015 Nov 1;16(11):969-72. doi: 10.1016/j.jamda.2015.05.012. Epub 2015 Jun 27.
5
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation.欧洲心房颤动患者的心率控制与节律控制和不良结局。
Europace. 2018 Feb 1;20(2):243-252. doi: 10.1093/europace/euw421.
6
Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.≥75 岁房颤患者的药物治疗、不良结局和治疗效果。
J Am Heart Assoc. 2020 Jun 2;9(11):e015089. doi: 10.1161/JAHA.119.015089. Epub 2020 May 23.
7
Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study.疾病群集与住院老年患者多重用药的关联:REPOSI 研究结果。
Eur J Intern Med. 2011 Dec;22(6):597-602. doi: 10.1016/j.ejim.2011.08.029. Epub 2011 Sep 29.
8
Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.心房颤动在评估心律失常控制的心脏节律紊乱登记处中的进展:临床相关性及节律控制治疗的影响。
Am Heart J. 2012 May;163(5):887-93. doi: 10.1016/j.ahj.2012.02.015.
9
Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.心房颤动合并起搏器患者的速率控制与节律控制比较。
Am J Cardiol. 2013 Jun 15;111(12):1759-63. doi: 10.1016/j.amjcard.2013.02.031. Epub 2013 Mar 27.
10
Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-Analysis.老年人房颤的心率控制与节律控制的临床转归:系统评价和荟萃分析。
Drugs Aging. 2020 Jan;37(1):19-26. doi: 10.1007/s40266-019-00722-4.

引用本文的文献

1
Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11-Year Real-World Registry.80岁及以上心房颤动患者的结局与疾病管理:来自连续11年真实世界注册研究的数据
J Am Heart Assoc. 2025 Feb 18;14(4):e036832. doi: 10.1161/JAHA.124.036832. Epub 2025 Feb 8.
2
Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.心房颤动的多学科治疗方法:堪比黄金。
J Clin Med. 2024 Aug 7;13(16):4621. doi: 10.3390/jcm13164621.
3
Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink.

本文引用的文献

1
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation.欧洲心房颤动患者的心率控制与节律控制和不良结局。
Europace. 2018 Feb 1;20(2):243-252. doi: 10.1093/europace/euw421.
2
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Europace. 2016 Nov;18(11):1609-1678. doi: 10.1093/europace/euw295. Epub 2016 Aug 27.
3
Rhythm control in atrial fibrillation.心房颤动的节律控制。
心房颤动中的多重用药:使用临床实践研究数据链对死亡率和缺血性卒中进行的前瞻性分析。
J Arrhythm. 2023 Nov 27;40(1):47-56. doi: 10.1002/joa3.12961. eCollection 2024 Feb.
4
Which Is Better? Rate Versus Rhythm Control in Atrial Fibrillation: A Systematic Review.哪种方法更好?心房颤动的心率控制与节律控制:一项系统评价。
Cureus. 2023 Dec 3;15(12):e49869. doi: 10.7759/cureus.49869. eCollection 2023 Dec.
5
The effect of treatment strategy on long-term follow-up results in patients with nonvalvular atrial fibrillation in Turkey: AFTER-2 subgroup analysis.土耳其非瓣膜性心房颤动患者治疗策略对长期随访结果的影响:AFTER-2 亚组分析。
Aging Clin Exp Res. 2023 Aug;35(8):1695-1704. doi: 10.1007/s40520-023-02467-y. Epub 2023 Jun 17.
6
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort.根据 4S-AF 特征方案和房颤患者的长期结局进行节律或速率控制策略:莫德纳房颤(Fibrillazione Atriale in Modena)队列研究。
Intern Emerg Med. 2022 Jun;17(4):1001-1012. doi: 10.1007/s11739-021-02890-x. Epub 2021 Dec 2.
7
Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-Analysis.老年人房颤的心率控制与节律控制的临床转归:系统评价和荟萃分析。
Drugs Aging. 2020 Jan;37(1):19-26. doi: 10.1007/s40266-019-00722-4.
8
Atrial Fibrillation in Older People: Concepts and Controversies.老年人的心房颤动:概念与争议
Front Med (Lausanne). 2019 Aug 8;6:175. doi: 10.3389/fmed.2019.00175. eCollection 2019.
9
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.老年人的多药治疗:来自 REPOSI 登记处 10 年经验的教训。
Intern Emerg Med. 2018 Dec;13(8):1191-1200. doi: 10.1007/s11739-018-1941-8. Epub 2018 Aug 31.
Lancet. 2016 Aug 20;388(10046):829-40. doi: 10.1016/S0140-6736(16)31277-6.
4
Rate control in atrial fibrillation.心房颤动的心率控制。
Lancet. 2016 Aug 20;388(10046):818-28. doi: 10.1016/S0140-6736(16)31258-2.
5
Stroke prevention in atrial fibrillation.心房颤动的卒中预防。
Lancet. 2016 Aug 20;388(10046):806-17. doi: 10.1016/S0140-6736(16)31257-0.
6
Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.导管消融治疗心房颤动与较低的卒中和死亡率相关:来自瑞典健康登记处的数据。
Eur Heart J. 2016 Aug;37(31):2478-87. doi: 10.1093/eurheartj/ehw087. Epub 2016 Mar 16.
7
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
8
Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.治疗 90 岁以上老年人的心房颤动:来自柏林心房颤动(BAF)登记研究的见解。
J Am Med Dir Assoc. 2015 Nov 1;16(11):969-72. doi: 10.1016/j.jamda.2015.05.012. Epub 2015 Jun 27.
9
Stroke prevention in atrial fibrillation: a systematic review.心房颤动的卒中预防:系统评价。
JAMA. 2015 May 19;313(19):1950-62. doi: 10.1001/jama.2015.4369.
10
Therapeutic management in ambulatory elderly patients with atrial fibrillation: the S.AGES cohort.门诊老年房颤患者的治疗管理:S.AGES 队列研究。
J Nutr Health Aging. 2015 Feb;19(2):219-27. doi: 10.1007/s12603-015-0444-9.